Dr. Pavel Aksionav, MD
- Part D claims, 2024
- 49
- Publications
- 2
- Industry payments
- $663
- Affiliated sites
- 2
- Medical group
- 1
- Practice address
- 1500 W Poplar Ave, Collierville, TN 38017
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Baptist Cancer Center Collierville - HOPD
Acute Care Hospital outpatient department · Collierville, Tennessee
Find Dr. Aksionav's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pavel Aksionav is an internist in Collierville, Tennessee
Dr. Aksionav practices at Baptist Cancer Center Collierville - HOPD in Collierville, Tennessee.
Dr. Aksionav's NPI, 1932728128, was assigned on April 9, 2020. Dr. Aksionav holds Tennessee license 70633.
- NPI
- 1932728128NPI Registry (opens in a new tab)
- NPI enumeration date
- April 9, 2020
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Pavel Aksionav practices at Baptist Cancer Center Collierville - HOPD in Collierville, Tennessee
Dr. Aksionav's primary practice is Baptist Cancer Center Collierville - HOPD, at 1500 W Poplar Ave, Collierville, TN 38017.
- Baptist Cancer Center Collierville - HOPD1500 W Poplar Ave, Collierville, TN 38017
Source: Dmand AI Affiliation Data
Dr. Pavel Aksionav is affiliated with 2 sites of care and 1 medical group
Dr. Aksionav's primary practice is Baptist Cancer Center Collierville - HOPD in Collierville, Tennessee. The medical group on file is Southeastern Physician Services PC. Dmand AI also links Dr. Aksionav to 1 more group practice or clinic, named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Pavel Aksionav's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aksionav practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Baptist Cancer Center Collierville - HOPD | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Pavel Aksionav is one of 2,427 internists in Tennessee
Internal medicine is Dr. Aksionav's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Aksionav is licensed in Tennessee.
Specialties and state licenses
- Internal medicine, TennesseePrimary
Internists near Dr. Aksionav
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Pavel Aksionav's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Aksionav's median patient age at 68, with 65% women.
Dr. Aksionav's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women65%
- Men35%
Source: Dmand AI Patient Panel Data
Dr. Pavel Aksionav wrote 49 Medicare Part D claims in 2024
In 2024, Dr. Aksionav wrote 49 Medicare Part D claims for 14 patients. 90% of them were for generic drugs. They cover 6 drugs, with $2,158 in total drug cost. In 2022, CMS named 165 claims across 8 drugs.
Dr. Aksionav's Part D claims by kind of drug, 2024
- Generic44 claims90%
- Brand-name and other5 claims10%
Dr. Aksionav's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1652023: 10536%
Drugs named by CMS: 6 in 2023, 8 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Pavel Aksionav has 2 publications on record
Dmand AI links 2 papers to Dr. Aksionav, published from 2020 to 2022. Dr. Aksionav's most frequent co-authors are Colin W. Howden, MD, Zaid Imam, MD and Dawit Kamil Jowhar, MD.
Dr. Aksionav's most frequent co-authors
Recent publications by Dr. Aksionav
Scand J Gastroenterol
See who Dr. Aksionav researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Aksionav works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Pavel Aksionav received $663 in industry payments from 2024 to 2025
CMS Open Payments shows 18 general payments to Dr. Aksionav from 13 drug and device companies from 2024 to 2025. Education make up the largest share, 59% of the total. Eli Lilly and Company paid the most, $225.
General payments to Dr. Aksionav by program year, 2024 to 2025
General payments to Dr. Aksionav by kind, 2024 to 2025
- Education$39259%
- Food and beverage$27141%
Companies that paid Dr. Aksionav the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Pavel Aksionav's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Pavel Aksionav
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Pavel Aksionav's NPI number?
Dr. Pavel Aksionav's NPI number is 1932728128. It was assigned on April 9, 2020, and it is active in the NPI Registry.
What kind of doctor is Dr. Pavel Aksionav?
Dr. Pavel Aksionav is an internist in Collierville, Tennessee. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Pavel Aksionav practice?
Dr. Aksionav practices at 1500 W Poplar Ave, Collierville, TN 38017. Dr. Aksionav's primary practice is Baptist Cancer Center Collierville - HOPD in Collierville, Tennessee. Dmand AI also links Dr. Aksionav to 1 group practice or clinic.
What is Dr. Pavel Aksionav's medical license number?
Dr. Aksionav holds Tennessee license 70633.
What medical group is Dr. Pavel Aksionav part of?
Dr. Aksionav is linked to Southeastern Physician Services PC.
What drugs does Dr. Pavel Aksionav prescribe most?
In 2023 Medicare Part D data, Dr. Aksionav's most prescribed drugs by claims were Atorvastatin Calcium, Amlodipine Besylate and Lisinopril.
Has Dr. Pavel Aksionav received payments from drug or device companies?
CMS Open Payments shows $663 in general payments to Dr. Aksionav from 13 companies from 2024 to 2025. The largest total came from Eli Lilly and Company.
How long has Dr. Pavel Aksionav been practicing?
Dr. Aksionav graduated from medical school in 2013, 13 years ago.
Does Dr. Pavel Aksionav do research?
Dmand AI links 2 publications to Dr. Aksionav, published from 2020 to 2022.
Who does Dr. Pavel Aksionav publish with?
Dr. Aksionav's most frequent co-authors are Colin W. Howden, MD (1 shared paper), Zaid Imam, MD (1 shared paper) and Dawit Kamil Jowhar, MD (1 shared paper).
Selling to internal medicine practices?
See internists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card